Michael L. F. Slavin is an entrepreneur, investor and President of U.S. Emerald Energy, an oil and gas exploration company. Mike served for ten years in the U.S. Army, first as an infantry officer and then as an aviation officer. He commanded two aviation units, served as an aide to the President of the United States during a state visit, and flew scouting missions over the Korean DMZ. While his current ventures have brought him personal and financial success, he also had some “in-between” years. He was in-between jobs, in-between businesses, in-between homes, in-between broke and just over broke. He was a headhunter, an insurance salesman, a self-employed mergers and acquisitions consultant, and the CEO of a title company. Today, Mike is passionate about giving back to his community and creating and sharing resources that help entrepreneurs succeed. His book tackles how to find a business idea and how to get it funded, offering some great, innovative ideas on both. He serves on the board of the charity Justice for Children and writes and speaks about entrepreneurship to a variety of audiences.
Dr. Peter Navarro – China Expert, Professor at UC Irvine and Author of Crouching Tiger: What China’s Militarism Means for the World
Dr. Peter Navarro is a professor at the Merage School of Business at the University of California-Irvine. With a Masters of Public Administration from the Kennedy School of Government and a Ph.D. in economics from Harvard, this distinguished macroeconomist has written extensively on Asia as well as lived and worked there. He has published ten previous books, most recently “Death by China”, “Seeds of Destruction”, “Always a Winner”, and the bestselling “The Coming China Wars.” In 2001, his ”If It’s Raining in Brazil, Buy Starbucks” was also a bestseller. He appears regularly in such media outlets as the BBC, CNN, CNBC, MSNBC, and the CBS News, including 60 Minutes. His op-ed articles have been published in the Boston Globe, the Chicago Tribune, the Los Angeles Times, the International Herald Tribune, the New York Times, and the Wall Street Journal, among other publications.